About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,809 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,809 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2041-2060 of 10,809 trials

CompletedReduced Intensity Transplant Conditioning Regimen for Severe ThalassemiaThis study is being done to determine if blood cell transplants, with either bone marrow or cord blood from unrelated donors, are effective in children with severe thalassemia and…NCT01005576·Los Angeles, California and 17 others CompletedEfficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary FibrosisORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.NCT05185089·Los Angeles, California and 36 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

UnknownSafety and Tolerability of HTI-1066 in Subjects With Advanced Solid TumorsHTI-1066 is a novel ADC being developed for the treatment of cancers in patients with overexpression of c-Met.NCT03398720·Scottsdale, Arizona and 2 others

RecruitingClinical Outcome Measure at Stryker SpineThis is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker…NCT06226272·Jacksonville, Florida and 6 others

CompletedSafety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring OpioidsThe purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years…NCT01192295·Birmingham, Alabama and 46 others

CompletedA Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host DiseaseThis study was been conducted to evaluate the safety, tolerability, and activity of belumosudil (formerly known as KD025) in adult participants with chronic graft versus host…NCT02841995·Duarte, California and 6 others

CompletedEvaluate ALLN-177 in Patients With Enteric HyperoxaluriaThe purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria.NCT03456830·Birmingham, Alabama and 62 others

TerminatedStudy of the Loss of AV Synchrony at Maximum ExerciseInvestigators will identify a group of patients with complete heart block and a dual chamber pacemaker who will be expected to be able to exercise on a treadmill.NCT03859167·Nashville, Tennessee

TerminatedStudy of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) PathwayThis is a multicenter clinical trial to evaluate DCC-3084 alone or in combination with other cancer therapies in participants with advanced cancers.NCT06287463·Los Angeles, California and 8 others

CompletedTelemedicine Follow-up for Patients With Cervical Dystonia Treated With Neurotoxin InjectionsMany cervical dystonia (CD) patients are limited in their ability to travel to the clinic for follow-up in between injection visits.NCT03969537·Nashville, Tennessee

CompletedCertolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to InfliximabTo assess the clinical efficacy of subcutaneous (sc) certolizumab pegol administration over 26 weeks in patients suffering from Crohn's Disease (CD) and previously treated with…NCT00308581·San Francisco, California and 106 others

TerminatedConnect® MM- The Multiple Myeloma Disease RegistryThe purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide…NCT01081028·Huntsville, Alabama and 252 others

CompletedThe FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial FibrillationThis is a prospective, adaptive, multi-center, randomized safety and effectiveness pivotal study comparing the FARAPULSE Pulsed Field Ablation System with standard of care…NCT04612244·Birmingham, Alabama and 33 others

Active not recruitingAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelThis randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with…NCT03419234·Fairbanks, Alaska and 671 others

CompletedStudy to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid TumorsThe primary objective of this study is to: * Evaluate the safety and tolerability of AMG 305 in adult participants * Determine the optimal biologically active dose (OBD), at or…NCT05800964·Duarte, California and 26 others

CompletedA Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.This is a two-part, Phase IIa, multicenter, 12-week, open-label study. Up to 56 participants with deletion AS aged 5-17 years (inclusive) will be enrolled in the study.NCT05630066·Chicago, Illinois and 18 others

TerminatedDocetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerRATIONALE: Dose-dense scheduling with (peg)filgrastim support may improve the clinical and pathologic complete response rate (pCR) and safety profile of single agent neoadjuvant…NCT00343512·Nashville, Tennessee and 1 other

CompletedA Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerThis randomized, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of onartuzumab (MetMAb) in combination with mFOLFOX6 in patients with…NCT01590719·Denver, Colorado and 35 others

CompletedAMPLATZER Duct Occluder II Clinical StudyThe objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.NCT00713700·San Diego, California and 24 others

Active not recruitingPAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville).NCT05037292·Palo Alto, California and 2 others

PreviousPage 103 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville